40
Participants
Start Date
October 31, 2009
Primary Completion Date
February 28, 2011
Study Completion Date
May 31, 2011
Pimecrolimus
"20 AD patients will be given pimecrolimus 1% to apply twice daily for up to three weeks on each lesional site predetermined at baseline. Lesional target site and non-lesional site will be determined at Visit 1.~Two 2 mm biopsies will be obtained from a target AD lesion and non-lesional sites at Visit 2, and Visit 3 (four biopsies each visit)."
Vehicle cream
"20 AD patients will be treated with vehicle cream twice daily for up to 3 weeks on each lesional site predetermined at baseline. Lesional target site and non-lesional site will be determined at Visit 1.~Two 2 mm biopsies will be obtained from a target AD lesion and non-lesional sites at Visit 2, and Visit 3 (four biopsies each visit)."
University of California, San Diego - Dept of Dermatology, La Jolla
Collaborators (1)
Novartis
INDUSTRY
University of California, San Diego
OTHER